STALNECKER SUSAN M 4

4 · Leidos Holdings, Inc. · Filed Feb 19, 2025

Form 4

Period: 2025-02-18

Director

Transactions

Exercise/Conversion
Common Stock
2025-02-18$63.08/sh+4,070$256,736→ 19,730 total
Exercise/Conversion
Common Stock
2025-02-18$75.02/sh+3,345$250,942→ 23,075 total
Exercise/Conversion
Common Stock
2025-02-18$103.90/sh+2,123$220,580→ 25,198 total
Exercise/Conversion
Common Stock
2025-02-18$104.06/sh+1,769$184,082→ 26,967 total
Exercise/Conversion
Common Stock
2025-02-18$79.45/sh+2,296$182,417→ 29,263 total
Tax Payment
Common Stock
2025-02-18$132.26/sh−8,278$1,094,848→ 20,985 total
Exercise/Conversion
Stock Option (Right to Buy)
2025-02-18−4,070→ 0 total
Exercise: $63.08From: 2019-04-26Exp: 2025-05-10→ Common Stock (4,070 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-02-18−3,345→ 0 total
Exercise: $75.02From: 2020-05-01Exp: 2026-05-09→ Common Stock (3,345 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-02-18−2,123→ 0 total
Exercise: $103.90From: 2022-04-29Exp: 2028-05-06→ Common Stock (2,123 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-02-18−1,769→ 0 total
Exercise: $104.06From: 2023-04-28Exp: 2029-05-05→ Common Stock (1,769 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-02-18−2,296→ 0 total
Exercise: $79.45From: 2024-04-26Exp: 2030-05-04→ Common Stock (2,296 underlying)

Footnotes (1)

[F1]Represents shares of common stock withheld by the issuer in connection with the option exercise to cover the exercise price and associated fees.

Documents

1 file